andrewlinscott / iStockphoto.com
The UK will fall outside of the European Medicines Agency (EMA) in the event of a no-deal Brexit, leaving the Medicines and Healthcare Products Regulatory Agency (MHRA) to take on the functions currently undertaken by the EU for medicines on the UK market.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Brexit, no-deal Brexit, stockpiling, regulation, EMA, regulatory, contingency plans, parallel imports , Bristows